Challenge Theme – AAV

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
CGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulationChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapies

Your privacy

We use cookies on this site to enhance your user experience.
By clicking the Accept button, you agree to us doing so. Find out more here.